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KEY POINTS
 Cancer risk in patients with colonic inflammatory bowel disease (IBD) is high and
increases over time. Quality and efficacy of surveillance is variable in routine clinical
practice.
 Chromoendoscopy (CE) is recommended by most societies as the preferred test for
colorectal cancer (CRC) surveillance in patients with colonic IBD. It has been shown
unequivocally to improve dysplasia detection on targeted biopsies.
 Narrow band imaging has not shown superior dysplasia detected on targeted biopsies
compared with CE or with white light imaging.INTRODUCTION
Patients with IBD involving the colon have an increased risk for CRC compared with
the general population.1 Cancer in ulcerative colitis (UC) occurs at a younger age
and increases with time, approaching 18% after 30 years of disease.1 This increased
risk has prompted both the North American and United Kingdom gastroenterology
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Subramanian & Bisschops394Surveillance colonoscopies for early detection have been widely adopted to
formally evaluate the benefits, risks, and costs of this approach.4–7 Despite surveil-
lance, interval cancer rates are high in these patients. A 2006 Cochrane review found
no clear evidence that surveillance colonoscopy prolongs survival in patients with
extensive colitis.8 In the same year, a 30-year analysis of surveillance practice from
St Mark’s hospital reported that more than 50% of detected cancers were found to
be interval cancers.4 These data reflect an era when dysplasia was perceived to be
invisible and only detected on random biopsies.9
In the past decade, endoscopic technology and technique has matured, with paral-
lel evidence showing that the vast majority of dysplasia is visible and can be targeted.
The long-term effects of surveillance using these new techniques, such as cancer-free
survival, are still unknown. In this review, the authors summarize the existing literature
on image-enhanced endoscopic techniques for surveillance of long-standing colonic
IBD for the detection of dysplasia. They focus on dye-based chromoendoscopic
techniques and present electronic-based image-enhanced endoscopic techniques
such as narrow band imaging and autofluorescence endoscopy. Confocal laser endo-
microscopy, a lesion characterization technology, is described in detail by Kiesslich
and Matsumoto in another article in this issue.SURVEILLANCE TECHNIQUES
Futility of White Light with Random Biopsy
Random mucosal sampling throughout the colon has historically been the mainstay
of IBD surveillance colonoscopy. The technique is tedious, expensive, and time
consuming, as it requires multiple biopsies to be taken segmentally throughout
the colon and processed in separate jars. It has been estimated that at least 33 bi-
opsies are needed to achieve 90% confidence to detect dysplasia if it is present.10
The technique is not only inefficient but also inefficacious. The yield from random
biopsy in studies on surveillance colonoscopy using high-definition (HD) endo-
scopes or other image-enhancement techniques is poor. Table 1 summarizes the
dysplasia yield from random biopsies for studies using image-enhanced endoscopic
technologies.
The need to adopt image-enhanced techniques with targeted lesion detection is
underscored by the low yield and unknown clinical significance from dysplasia found
on random biopsies. Van den Broek and colleagues20 published a retrospective anal-
ysis of the yield of dysplasia and clinical significance of dysplasia detected in random
biopsies. Of 466 colonoscopies involving 167 patients done in a 10-year period from
1998 to 2008, dysplasia was detected by random biopsy only in 5 colonoscopies
involving 4 patients. Only in one of these patients did protocolectomy confirm the
presence of advanced neoplasia.
Superiority of Chromoendoscopy with Targeted Biopsy
The British Society of Gastroenterology21 and the European Crohn’s and Colitis orga-
nization22 have specified chromoendoscopy (CE) as the preferred modality for surveil-
lance in patients with colonic IBD. CE refers to the topical application of dyes (indigo
carmine23 or methylene blue24) to improve detection and delineation of surface abnor-
malities by pooling into mucosal crevices. Its application enhances the detection of
subtle mucosal abnormalities to improve the yield of surveillance,16 compared with
white light inspection alone. Both indigo carmine and methylene blue have been
widely used and shown to be effective. CE was first shown to be useful in the detection
of flat adenomas in the sporadic setting and in patients with familial polyposis
Table 1
Yield of dysplasia from random biopsies in prospective endoscopic studies involving surveillance colonoscopy with image-enhanced endoscopy for colonic
IBD in the last 10 years
Study Author, Year Country Image-Enhanced Modality Used
Number of
Patients
Number of
Random Biopsies
with Dysplasia
Total Number
of Random
Biopsies
Mean Number of
Random Biopsies
per Episode of
Dysplasia
Kiesslich et al,11 2003 Germany Methylene blue chromoendoscopy 165 2 (in white light
arm only)
5098 2549
Matsumoto et al,12 2003 Japan Indigo carmine chromoendoscopy 57 3 702 234
Rutter et al,13 2004 United Kingdom Indigo carmine chromoendoscopy 100 0 2904 —
Kiesslich et al,14 2007 Germany Methylene blue chromoendoscopy 153 2 (in white light
arm only)
2854 1427
Dekker et al,15 2007 Netherlands Narrow Band Imaging (first
generation)
42 1 1522 1522
Van den Broek et al,16 2008 Netherlands Autofluorescence endoscopy 50 2 1992 996
Marion et al,17 2008 USA Methylene blue chromoendoscopy 102 3 3264 1088
Van den Broek et al,18 2011 Netherlands Narrow Band Imaging (second
generation)
48 3 1580 527
Ignjatovic et al,19 2012 United Kingdom Narrow Band Imaging (second
generation)
112 1 2707 2707
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Subramanian & Bisschops396syndromes25,26; during the past decade, studies have also shown CE to augment the
visualization of dysplasia in UC.27,28
Table 2 lists the published studies comparing pancolonic CE with WLE for detection
of dysplasia in colonic IBD. A meta-analysis of the available data in 201132 and an
updated one in 201333 that included 6 studies with 665 patients confirmed the supe-
riority of CE with targeted biopsy to standard WLE with random biopsy. A 6% increase
in the yield of dysplasia was noted in the most recent analysis, leading to a number
needed to treat of 16 to detect an additional patient with dysplasia if using CE with
targeted biopsy. Compared with white light, the use of CE added almost 11 minutes
to the total procedure time, which also included the time spent on random biopsies.
Improvements in detection and visualization of dysplasia in patients with IBD have
led to an increase in their local endoscopic resection, without the need for colec-
tomy,34 all emphasizing the importance of careful and complete surveillance colonos-
copies in these high-risk patients. Although CE is increasingly recommended for this
purpose,35,36 it has yet to be widely adopted as standard of care in clinical practice.
Some of the reasons for this may be because CE is perceived as time consuming and
often messy. These and perhaps additional factors like differences in application
technique (spray catheter vs foot pump), dye contact time, operator experience,
and interpretation of staining are the important training ingredients to broadly imple-
ment CE into routine clinical practice. Picco and colleagues31 have shown excellent
interobserver agreement among nonexpert endoscopists in the detection and inter-
pretation of lesions detected by CE and the suggested steps toward training a unit
to implement CE.
High-Definition Electronic Image-Enhanced Endoscopy (Virtual Chromoendoscopy)
CE with indigo carmine or methylene blue has been well demonstrated and is now
incorporated into surveillance guidelines.21 However, the perceived increased effort,
skill, time, and cost of CE have motivated studies on electronic-based image-
enhanced endoscopy or dyeless virtual CE. Three different systems are commercially
available: Narrow Band imaging (NBI, Olympus, Tokyo, Japan), Fujinon Intelligent
Color Enhancement (FICE, Fujifilm, Tokyo, Japan), and i-scan (Pentax, Tokyo, Japan).
The basic principle of all these enhancement techniques is to filter the classical white
light images to enhance superficial structural and vascular changes in the mucosa. In
case of NBI, an optical filter is placed in front of the excitation white light source to
narrow the wavelength to 30-nm bandwidths in the blue (415 nm) and green
(540 nm) regions of the spectrum. Superficial mucosal structures (pit patterns) and
microvasculature are enhanced using a narrow band light because it has more shallow
tissue penetration and is mostly absorbed by hemoglobin in the vessels.
In contrast to NBI, the FICE and i-scan techniques do not use a physical filter but a
postprocessing spectrum analysis software to enhance the image features and char-
acteristics. The video processor disintegrates the different red green blue components
of the white light image. Each component is then independently converted along its
tone curve, followed by resynthesis of the 3 components to reconstruct a new digital
image.37–41 In theory, the number of possible combinations is endless, but each sys-
tem comes with readily available filters. For example, the FICE system has 10 available
filters, which can be activated by a push of the button and can be changed on the
numeric key path of the processor’s keyboard. Pentax has 3 major i-scan presets
with standardized surface, tone, and contrast enhancement that come as a factory
setting.
Because all these techniques are standardly available and can be simply activated
by pushing a button, they have the appeal to overcome the technical drawbacks of
Table 2
Published studies comparing pancolonic chromoendoscopy with white light endoscopy in detection of dysplastic lesions for surveillance colonoscopy in
long-standing colonic IBD
Author, Year Country
No. of
Endoscopists Dye Study Design Inclusion Criteria
No. of
Patients
No. with
Dysplasia
Was CE
Bettera
Kiesslich et al,11 2003 Germany Multiple MB Randomized 1:1 Long-standing UC 8 y 165 18 Y
Matsumoto et al,12 2003 Japan Single IC Prospective cohort, WLE
followed by CE
Pancolitis >5 y 57 12 Y
Rutter et al,13 2004 UK Single IC Prospective cohort, WLE
followed by CE
Long-standing extensive UC 100 7 Y
Kiesslich et al,14 2007 Germany Multiple MB Randomized 1:1 Long-standing UC 8 y 153 15 Y
Marion et al,17 2008 USA Multiple MB Prospective cohort, WLE
followed by CE
Extensive UC or Crohn’s colitis
involving >1/3 of colon
102 22 Y
Gu¨nther et al,29 2011 Germany Multiple IC Subdivided retrospectively into
50 patients in each group
Extensive UC >8 y or colonic
Crohn’s colitis >10 y
100 2 N
Hlavaty et al,30 2011 Slovakia Multiple IC Retrospective analysis based on
consent for WLE alone or WLE
followed by CE
Pancolitis >8 y or left sided
colitis >15 y
45 6 Y
Picco et al,31 2013 USA Multiple IC Prospective cohort WLE
followed by CE
Long standing extensive
UC >8 y
75 16 Y
Abbreviations: IC, indigo carmine; MB, methylene blue; N, no; Y, yes.
a Detection by CE was significantly (P<.05) better than by WLE.
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Subramanian & Bisschops398dye-based CE. In non-IBD settings, the diagnostic accuracy of NBI, FICE, and i-scan
in discriminating neoplastic from nonneoplastic lesions is comparable to dye-based
CE,42–46 and at least this aspect of the technique seems to have a short learning
curve.47,48
To date, the only electronic image-enhanced endoscopic technique to be assessed
for diagnostic accuracy in IBD, however, has been using NBI. Five randomized tri-
als15,18,19,49,50 using NBI compared with CE (n 5 2) or white light imaging (n 5 3)
did not show superiority in the detection of neoplastic lesions in long-standing colitis.
Dekker and colleagues15 showed no diagnostic advantage in a tandem colonoscopic
study that compared the first-generation NBI system to standard-resolution WLE for
the detection of colitis-associated neoplasia. NBI detected 52 visible lesions in 17 pa-
tients (8 neoplastic), compared with 28 visible lesions in 13 patients (7 neoplastic)
during WLE inspection. Two more trials comparing HD-NBI to WLE also found no sig-
nificant difference in the detection of neoplastic lesions when using NBI. Van den
Broek and colleagues18 performed a tandem colonoscopy study and found 13 of 16
(81%) neoplastic lesions using HD-NBI compared with 11 of 16 (69%) neoplastic le-
sions using HD-WLE.18 Random biopsy protocol yielded no significant additional
neoplasia; in a total of 1590 random biopsies, 3 demonstrated low-grade dysplasia
of which 2 were found in the proximity of dysplasia associated lesion or mass lesions.
Ignjatovic and colleagues19 assessed the diagnostic yield of HD-NBI compared with
WLE in a randomized controlled trial without back-to-back design and could not
find a significant difference in neoplasia detection between the 2 techniques (5
neoplastic lesions in 5 patients for HD-NBI vs 7 neoplastic lesions in 5 patients for
HD-WLE). Only 1 in 2707 random biopsies yielded an additional diagnosis of low-
grade dysplasia in a patient who already had a lesion detected by NBI-targeted bi-
opsies.19 These studies add further to the evidence random biopsies are low yield
and should be abandoned.18,19,51
Two trials have compared HD-NBI to CE. In a back-to-back study,49 33 patients
underwent HD colonoscopy with NBI followed by CE (0.5% indigo carmine) and 27 pa-
tients were randomized to the opposite sequence to assess miss rates of the 2 tech-
niques. The study showed a nonsignificant trend toward a higher miss rate using NBI.
In the NBI first group, NBI detected 7 neoplastic lesions in 4 patients during the first
pass and CE detected 5 additional lesions in 4 patients during the second pass. In
the HD-CE first group, CE detected 5 neoplastic lesions in 4 patients during the first
pass and NBI detected 3 neoplastic lesions in 1 patient during the second pass.
The withdrawal time for CE was significantly longer (26.87  9.89 minutes for CE vs
15.74 5.62 minutes for NBI, P<.01).49 Preliminary abstract data of a randomized trial
comparing HD-NBI with CE (0.1%methylene blue) showed no significant difference in
neoplasia detection rates between either modalities (18.5% for HD-NBI and 16.7% for
HD-CE, P 5 .658).50
At present, CE remains the gold standard for colitis surveillance. Further studies
assessing NBI or other electronic image-enhanced endoscopic methods compared
with CE are necessary before any change in recommendations or clinical practice.
Autofluorescence Imaging
Autofluorescence imaging (AFI) is a novel imaging technique. AFI is available on the
monochrome chip (Lucera, Olympus, Tokyo, Japan), which has 2 charge-coupled de-
vices for WLE and AFI and can be activated by a push of the button. An ultraviolet filter
is placed in front of the light source. All tissues exhibit autofluorescence when excited
by ultraviolet (>400 nm) or short visible light (400–550 nm). Autofluorescence is gener-
ated by fluorophores, certain biomolecules (collagen, elastin), emitting a longer
Image-Enhanced Endoscopy in Colonic IBD 399wavelength than the excitation light. AFI is influenced by several factors, including tis-
sue architecture (mucosal thickening), light absorption and scattering properties
(mainly determined by the absorptive capacity of hemoglobin in neoplastic neovascu-
larization), the biochemical content (concentration of fluorophores), and metabolic
status of the tissue.52–59 Using AFI, neoplastic tissue is visible as a purple lesion on
a greenish background fluorescence of normal colonic tissue. AFI has therefore the
potential to serve as a red flag technique highlighting even very early minute neoplastic
changes in the colonic mucosa. In contrast to NBI, the available data on AFI for colitis
surveillance is sparse. In a single prospective randomized crossover trial comparing
the neoplasia detection of WLE with that of AFI targeted biopsies, Van den Broek
and colleagues16 found a significant higher yield for AFI. In the AFI first group, 10 le-
sions in 25 patients were detected and subsequent WLE did not detect any additional
lesions. However, in the WLE first group, 3 neoplastic lesions were detected in 25 pa-
tients, but AFI additionally detected 3 lesions. This resulted in a significantly different
miss rate (50% vs 0, P 5 .036) between the 2 techniques.16 Further larger trials are
needed to confirm the potential of this red flag technique and to compare its yield
with that of CE-guided biopsies.
SUMMARY
Patients with long-standing extensive colitis are at increased risk for developing
neoplasia and the literature suggests that surveillance endoscopy reduces mortality
from CRC in these patients. CE with indigo carmine or methylene blue has replaced
random biopsies as a standard for surveillance in these patients; this is supported
by several clinical trials and incorporated in recent guidelines. Future studies on digi-
tally enhanced imaging, such as NBI, will continue to be of interest, but one has to be
cautious that current data do not show their superiority compared with CE.
Future unmet needs in colitis surveillance include proper training and implementa-
tion for all endoscopists. Although the evidence is abundant and supports the use of
CE, it is far from being widely implemented outside of tertiary referral centers. The min-
imal criteria need to be standardized to determine properly trained endoscopists. An
endoscopist may need to start with CE coupled with 4-quadrant biopsies and
then cautiously proceed with CE-guided biopsies once competence metrics are
met. The implementation of these techniques needs to be monitored in prospective
quality registries to ensure patient safety and the performance by secondary care
gastroenterologists.
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